Resources
News feed
HIV patients with viral hepatitis are three times more likely to have liver disease, liver failure and liver-related deaths
On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2015 -...
Innovative patent agreement shows success of patient advocacy
The World Hepatitis Alliance congratulates the Medicines Patent Pool (MPP) and Bristol – Myers Squibb (BMS) for recognising the global hepatitis...
Medicines Patent Pool expands its mandate to hepatitis C treatment
The World Hepatitis Alliance welcomes the recent announcement from the Medicines Patent Pool (MPP) that they will be expanding their mandate to...
The global hepatitis community unites to demand access to life-saving hepatitis treatment
London, 2 November 2015: Today the World Hepatitis Alliance launches an open letter calling for immediate action to vastly improve access to life-...
Webinar on the Global Movement to Eliminate Viral Hepatitis
Learn more about the global movement to eliminate viral hepatitis. On 28 th October WHA President Charles Gore and WHA Executive Board Member for the...
WHO Regional Committee meetings see regions commit to tackling viral hepatitis
Despite viral hepatitis impacting almost every country in the world, the burden differs significantly from region to region. In order to achieve...
Expanding the membership base of the World Hepatitis Alliance
The membership base of the World Hepatitis Alliance continues to go from strength to strength as we welcome five new organisations. Our membership is...
Looking ahead to the next Summit
Following the first World Hepatitis Summit that took place in Glasgow, Scotland 2-4 September, we are already looking ahead to the next Summit. The...
Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025
By Keith Alcorn, Infohep.org Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global...
Medicines Patent Pool looks at hepatitis C
By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...
World Health Organization calls for ambitious global targets for viral hepatitis control
By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...
New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit
New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...
World Hepatitis Summit: New data shows relentless rise in hepatitis deaths
New data shows relentless rise in hepatitis deaths: World leaders meet in Scotland to discuss urgent response and move towards elimination of 7th...
Is the elimination of viral hepatitis on the horizon?
Today marks the fifth official World Hepatitis Day where members of the public and the hepatitis community provide a voice for the 4000 lives lost...
Welcoming new members to the World Hepatitis Alliance
Over the past few months we have welcomed a surge of new members to the World Hepatitis Alliance and we are proud to now have 216 member groups in 80...
2 weeks until World Hepatitis Day!
July 28 is now fast approaching and it’s set to be the biggest World Hepatitis Day yet! But we need your support to ensure we reach as many people as...
Calling for greater commitment to the fight against hepatitis at the World Health Assembly
The 68th session of the World Health Assembly (WHA68) took place in Geneva from 18th-26th May. On 25th May, the World Hepatitis Alliance was invited...
Working closely with WHO to develop a global strategy
WHO Strategic and Technical Advisory Committee for hepatitis (STAC-HEP) meeting, Geneva, Switzerland, 19 – 20 February As part of an expert advisory...
Supporting the launch of guidelines and policies to address viral hepatitis
WHO Injection Safety policy Every year 1.7 million people are infected with hepatitis B through unsafe injection and 315,000 with hepatitis C. Yet up...
Highlighting the importance of patient advocacy at international conferences
24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...